MW
Matthew Winkler
Angel InvestorQuietDr. Matt Winkler is CEO of Asuragen, Inc. He received a B.S. degree in Genetics and a Ph.D. in Zoology from the University of California at ...
1
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Matthew Winkler.
Investment Thesis & Strategy
As an angel investor, Dr. Winkler invests in various stages of biotech, pharmaceutical, and healthcare companies, likely seeking innovative ventures with strong scientific foundations.
Frequently Asked Questions
Matthew Winkler focuses on Pre-seed, Seed stage investments.